23 Jan 2023

Reminder: Have your say on the National Dementia Action Plan

The National Dementia Action Plan is open for consultation. Find out about the plan and how to provide feedback

23 Jan 2023

Reminder: Have your say on the National Dementia Action Plan

The National Dementia Action Plan is open for consultation. Find out about the plan and how to provide feedback

20 Jan 2023

Expressions of interest to join the Australian Technical Advisory Group on Immunisation

We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert

20 Jan 2023

Expressions of interest to join the Australian Technical Advisory Group on Immunisation

We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert

20 Jan 2023

Expressions of interest to join the Australian Technical Advisory Group on Immunisation

We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert

16 Mar 2023

Discovering an Australian antiviral drug for COVID-19

In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs

16 Mar 2023

Discovering an Australian antiviral drug for COVID-19

In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs

16 Mar 2023

Discovering an Australian antiviral drug for COVID-19

In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs

13 Jan 2023

Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022

From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).

13 Jan 2023

Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022

From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).